Mydecine Innovations

Healthcare  |  Drug Manufacturers—Specialty & Generic
0.40 0.0147 3.86%
Stock Price | Aug. 14, 2020, 3:44 p.m.
Bid: 0.361
Ask: 0.405
Prev. Close: 0.3808
52 Week Low: 0.3185
52 Week High: 0.578
PE Ratio: 0.0
Dividend Yield: 0.0%

Company Summary

Mydecine Innovations Group Inc operates hemp-derived CBD and psilocybin brands, It is engaged in designing, manufacturing, and distribution of advanced products. The firm is involved in cultivation, processing, product development, and research and development ofmycology's compounds through its three divisions namely Mydecine Farms, Mydecine Wellness, and Mydecine Labs.

Read more Read less

Recently Viewed Tickers